In implementing the Digital Medical Device Cross-Domain Integration and Development Project, organized by the Industrial Development Administration of the Ministry of Economic Affairs, the Metal Industries Research & Development Centre (MIRDC) is helping medical device companies overcome regulatory hurdles to accelerate the acquisition of domestic and international permits and clinical validations while integrating marketing efforts to push systemic solutions into the global market. To strengthen the adoption of domestic digital medical devices, MIRDC and Kaohsiung Medical University (KMU) co-hosted the Taiwan-Made Digital Medical Device Clinical Application Results Exchange Meeting on December 15, 2025, at KMU, inviting domestic digital medical device startups, clinicians, and industry representatives to share key milestones and success stories from R&D to clinical validation, showcasing Taiwan’s profound expertise in digital healthcare. The meeting attracted over 100 healthcare professionals, academic and research institutions, and medical device companies. Through product demonstrations and sharing of clinical experiences, the meeting fostered industry-academia-research connections, accelerating the development of Taiwan-made medical devices toward intelligence, digitalization, and globalization.
Chien-Zie Chen, Chairman of KMU, noted that clinical validation is critical for healthcare innovation; only by involving medical teams throughout the R&D process can technology truly meet clinical needs. MIRDC and KMU have a long-standing partnership committed to converting R&D results into practical applications by starting from clinical needs, introducing innovative technologies such as AI-assisted diagnostics, helping hospitals optimize care workflows and enhance healthcare quality, and moving domestic medical devices from the laboratory to large-scale deployment through clinical validation and cross-hospital implementation. Going forward, the partnership will continue to promote proof of concept initiatives, aiming to create a benchmark for domestically developed smart healthcare and empower Taiwan’s digital medical devices to enter clinical practice and go global, becoming a key driver for next-generation healthcare innovation.
Chia-Ju Liu, Chairman of MIRDC, stated that MIRDC possesses comprehensive R&D capabilities ranging from product design and processing to system integration. It also offers one-stop services like pre-clinical validation and regulatory guidance, actively helping Taiwan’s medical device manufacturers from design and verification to clinical validation and market entry. Chairman Liu also expressed gratitude to Dr. Bol-Wei Huang and Assistant Chief Yu-Chueh Wang for their long-term dedication to the medical device field. This meeting showcased a range of innovative technologies and clinical validations, including Compal Electronics, Inc.’s AI-powered cardiovascular imaging segmentation and annotation platform, Imvitec Corporation’s clinical diagnosis and treatment image prediction and evaluation system for brain radiation therapy, Home Clinic Dulan’s clinical site for home-based acute and chronic care, and Puli Christian Hospital Mei Men Kou Physical Therapy Clinic’s data-driven intelligent robotic rehabilitation system for stroke and neurological diseases, demonstrating the strong competitiveness of Taiwan-developed technologies.